Rectal cancer is the most common site in the colorectal spectrum and many patients present at an advanced stage. Short course radiotherapy is proposed as neo-adjuvant therapy to qualified patients as it is less expensive, requires less time, has greater compliance and less acute toxity, without compromising efficacy.